Skip to main content

Table 1 Patient characteristics

From: Expression of the Tpl2/Cot oncogene in human T-cell neoplasias

Patient no. Disease Sex Age %T+NKcells/PBMC Disease state Co-existent conditions
1 SS F 88 87 PP  
2 CTCL with monoclonal T- LGL lymphocytosis M 63 86 RD  
3 T-LGL leykemia F 75 93 RD Neutropenia
4 MF M 91 71 RD  
5 MF M 85 71 RD  
6 TLL F 35 77 RD  
7 T-PLL M 85 67 RD Myositis
8 Chronic NK -lymphocytosis F 67 64 Stable for two years Neutropenia
9 T-ALL M 16 95 LB RD  
10 T-LGL leukaemia with reactive NK lymphocytosis F 60 71 Stable for 10 years Sarcoidosis (past), neutropenia
11 PTCL secondary to MF M 52 85 PR  
12 Pre-T-ALL M 37 95 LB RD  
  1. Abbreviations: SS, Sezary syndrome; CTCL, Cutaneous T cell Lymphoma; T-LGL, T-large granular lymphocyte; MF, Mucosis Fungoides; NK, natural killer cell; TLL, T-lymphoblastic lymphoma; T-PLL, T-Prolymphocytic leukemia; T-ALL, T-acute lymphoblastic leukemia; LB, Lymphoblast ;PP, primary progressive; RD, recently diagnosed; PR, partial response.